HSR22-149: Adverse Events Among Cancer Patients Treated With a Combination of Nivolumab and Ipilimumab as Compared to Nivolumab Monotherapy: A Systematic Review and Meta-Analysis

Authors:
Shweta Kamat University of Rhode Island, Kingston, RI

Search for other papers by Shweta Kamat in
Current site
Google Scholar
PubMed Close
 MS
,
Jay Patel University of Rhode Island, Kingston, RI

Search for other papers by Jay Patel in
Current site
Google Scholar
PubMed Close
 PharmD Candidate
,
Britny Brown University of Rhode Island, Kingston, RI

Search for other papers by Britny Brown in
Current site
Google Scholar
PubMed Close
 PharmD, BCOP
, and
Ami Vyas University of Rhode Island, Kingston, RI

Search for other papers by Ami Vyas in
Current site
Google Scholar
PubMed Close
 PhD, MBA
Volume/Issue:
Volume 20: Issue 3.5
Online Publication Date:
31 Mar 2022
DOI:
https://doi.org/10.6004/jnccn.2021.7220
Restricted access

Corresponding Author: Shweta Kamat, MS
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2022 by the National Comprehensive Cancer Network 2022
Article Category:
Abstract
Print Publication Date:
31 Mar 2022
Online Publication Date:
31 Mar 2022

Metrics